<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39451477</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9032</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>20</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>17</Day></PubDate></JournalIssue><Title>Healthcare (Basel, Switzerland)</Title><ISOAbbreviation>Healthcare (Basel)</ISOAbbreviation></Journal><ArticleTitle>Prevalence, Risk Factors, and Impact of Long COVID Among Adults in South Korea.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2062</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/healthcare12202062</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This study aimed to identify the prevalence, risk factors, and impact of long COVID in a community-based representative sample of patients with COVID-19 aged 19-64 years.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A total of 975 participants completed online or telephone surveys at 1 and 3 months post-diagnosis, covering persistent symptoms, daily activity limitations, vaccination status, and underlying diseases.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Long COVID, as defined by the WHO criteria, had a prevalence of 19.7-24.9% in females and 12.7% in males. Logistic regression revealed that the odds of having long COVID symptoms were higher among females compared to males (OR, 2.43; 95% CI, 1.53-3.87), and higher in those aged &#x2265; 30 years compared to those aged 19-29 years: 30-39 years (OR, 2.91; 95% CI, 1.59-5.33), 40-49 years (OR, 2.72; 95% CI, 1.51-4.89), and 50-64 years (OR, 1.96; 95% CI, 1.10-3.49). Additionally, patients with underlying diseases had higher odds of long COVID symptoms compared to those without underlying diseases (OR, 1.81; 95% CI, 1.24-2.64). Among those with long COVID, 54.2% experienced daily activity limitations, and 40.6% received treatment. Furthermore, lower income groups faced greater daily activity limitations but had similar treatment rates to higher income groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These findings emphasize the need for interest in and the development of programs to support these low-income populations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Son</LastName><ForeName>Ha-Eun</ForeName><Initials>HE</Initials><AffiliationInfo><Affiliation>Department of Preventive Medicine, College of Medicine, Dong-A University, Busan 49201, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Disease Research Center, Green Cross Laboratories, Yongin 16924, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Young-Seoub</ForeName><Initials>YS</Initials><Identifier Source="ORCID">0000-0002-9037-3761</Identifier><AffiliationInfo><Affiliation>Department of Preventive Medicine, College of Medicine, Dong-A University, Busan 49201, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Seungho</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7069-267X</Identifier><AffiliationInfo><Affiliation>Department of Preventive Medicine, College of Medicine, Dong-A University, Busan 49201, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Son</LastName><ForeName>Hyunjin</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-6571-5109</Identifier><AffiliationInfo><Affiliation>Department of Preventive Medicine, College of Medicine, Dong-A University, Busan 49201, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2022R1F1A106619512</GrantID><Agency>The National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Healthcare (Basel)</MedlineTA><NlmUniqueID>101666525</NlmUniqueID><ISSNLinking>2227-9032</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">daily activity limitations</Keyword><Keyword MajorTopicYN="N">post-COVID-19 condition</Keyword><Keyword MajorTopicYN="N">prevalence</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword><Keyword MajorTopicYN="N">symptoms</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>12</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>9</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39451477</ArticleId><ArticleId IdType="pmc">PMC11506880</ArticleId><ArticleId IdType="doi">10.3390/healthcare12202062</ArticleId><ArticleId IdType="pii">healthcare12202062</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladds E., Rushforth A., Wieringa S., Taylor S., Rayner C., Husain L., Greenhalgh T. Persistent symptoms after COVID-19: Qualitative study of 114 &#x201c;long COVID&#x201d; patients and draft quality principles for services. BMC Health Serv. Res. 2020;20:1144. doi: 10.1186/s12913-020-06001-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-020-06001-y</ArticleId><ArticleId IdType="pmc">PMC7750006</ArticleId><ArticleId IdType="pubmed">33342437</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE)  COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19.  [(accessed on 1 March 2023)].  Available online:  https://www.nice.org.uk/guidance/ng188.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institutes of Health (NIH)  NIH Launches New Initiative to Study &#x201c;Long COVID&#x201d;.  [(accessed on 1 March 2023)]; Available online:  https://covid19.nih.gov/covid-19-topics/long-covid.</Citation></Reference><Reference><Citation>World Health Organisation (WHO)  A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus, 6 October 2021.  [(accessed on 1 March 2023)].  Available online:  https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.</Citation></Reference><Reference><Citation>Raman B., Cassar M.P., Tunnicliffe E.M., Filippini N., Griffanti L., Alfaro-Almagro F., Okell T., Sheerin F., Xie C., Mahmod M., et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine. 2021;31:100683. doi: 10.1016/j.eclinm.2020.100683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100683</ArticleId><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollini M., Ciccarelli M., Cecconi M., Aghemo A., Morelli P., Gelardi F., Chiti A. Vasculitis changes in COVID-19 survivors with persistent symptoms: An [18F]FDG-PET/CT study. Eur. J. Nucl. Med. Mol. Imaging. 2021;48:1460&#x2013;1466. doi: 10.1007/s00259-020-05084-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-05084-3</ArticleId><ArticleId IdType="pmc">PMC7595761</ArticleId><ArticleId IdType="pubmed">33123760</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A., Cuthbertson D.J., Wootton D., Crooks M., Gabbay M., Eichert N., Mouchti S., Pansini M., Roca-Fernandez A., Thomaides-Brears H., et al. Multi-organ impairment and long COVID: A 1-year prospective, longitudinal cohort study. J. R. Soc. Med. 2023;116:97&#x2013;112. doi: 10.1177/01410768231154703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768231154703</ArticleId><ArticleId IdType="pmc">PMC10041626</ArticleId><ArticleId IdType="pubmed">36787802</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan L., Mu M., Yang P., Sun Y., Wang R., Yan J., Li P., Hu B., Wang J., Hu C., et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: A descriptive, cross-sectional, multicenter study. Am. J. Gastroenterol. 2020;115:766&#x2013;773. doi: 10.14309/ajg.0000000000000620.</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ajg.0000000000000620</ArticleId><ArticleId IdType="pmc">PMC7172492</ArticleId><ArticleId IdType="pubmed">32287140</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y., Kim S.E., Kim T., Yun K.W., Lee S.H., Lee E., Seo J.-W., Jung Y.H., Chong Y.P. Preliminary Guidelines for the Clinical Evaluation and Management of Long COVID. Infect. Chemother. 2022;54:566&#x2013;597. doi: 10.3947/ic.2022.0141.</Citation><ArticleIdList><ArticleId IdType="doi">10.3947/ic.2022.0141</ArticleId><ArticleId IdType="pmc">PMC9533168</ArticleId><ArticleId IdType="pubmed">36196612</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabacof L., Tosto-Mancuso J., Wood J., Cortes M., Kontorovich A., McCarthy D., Rizk D., Rozanski G., Breyman E., Nasr L., et al. Post-acute COVID-19 syndrome negatively impacts physical function, cognitive function, health-related quality of life, and participation. Am. J. Phys. Med. Rehabil. 2022;101:48&#x2013;52. doi: 10.1097/PHM.0000000000001910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0000000000001910</ArticleId><ArticleId IdType="pmc">PMC8667685</ArticleId><ArticleId IdType="pubmed">34686631</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO)  Statement&#x2014;36 Million People across the European Region May Have Developed Long COVID over the First 3 Years of the Pandemic, 27 June 2023.  [(accessed on 1 March 2023)].  Available online:  https://www.who.int/europe/news/item/27-06-2023-statement---36-million-people-across-the-european-region-may-have-developed-long-covid-over-the-first-3-years-of-the-pandemic.</Citation></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: Putative pathophysiology, risk factors, and treatments. Infect. Dis. 2021;53:737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: A meta-analysis and systematic review. J. Infect. Dis. 2022;226:1593&#x2013;1607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO)  Weekly Epidemiological Update on COVID-19.  [(accessed on 20 June 2023)].  Available online:  https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---15-june-2023.</Citation></Reference><Reference><Citation>Kim Y., Bitna-Ha, Kim S.W., Chang H.H., Kwon K.T., Bae S., Hwang S. Post-acute COVID-19 syndrome in patients after 12 months from COVID-19 infection in Korea. BMC Infect. Dis. 2022;22:93. doi: 10.1186/s12879-022-07062-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07062-6</ArticleId><ArticleId IdType="pmc">PMC8793328</ArticleId><ArticleId IdType="pubmed">35086489</ArticleId></ArticleIdList></Reference><Reference><Citation>Soh H.S., Cho B.L. Long COVID-19 and health-related quality of life of mild cases in Korea: 3-months follow-up of a single community treatment center. J. Korean Med. Sci. 2022;37:e326. doi: 10.3346/jkms.2022.37.e326.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2022.37.e326</ArticleId><ArticleId IdType="pmc">PMC9705205</ArticleId><ArticleId IdType="pubmed">36631024</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y., Kim S.W., Chang H.H., Kwon K.T., Bae S., Hwang S. Significance and associated factors of long-term sequelae in patients after acute COVID-19 infection in Korea. Infect. Chemother. 2021;53:463&#x2013;476. doi: 10.3947/ic.2021.0022.</Citation><ArticleIdList><ArticleId IdType="doi">10.3947/ic.2021.0022</ArticleId><ArticleId IdType="pmc">PMC8511373</ArticleId><ArticleId IdType="pubmed">34405592</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health Research (NIHR)  Living with COVID-19&#x2014;Second Review.  [(accessed on 1 March 2023)].  Available online:  https://evidence.nihr.ac.uk/collection/living-with-covid19-second-review/</Citation></Reference><Reference><Citation>Lee H., Sung H.K., Lee D., Choi Y., Lee J.Y., Lee J.Y., Oh M.D. Comparison of complications after coronavirus disease and seasonal influenza, South Korea. Emerg. Infect. Dis. 2022;28:347&#x2013;353. doi: 10.3201/eid2802.211848.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2802.211848</ArticleId><ArticleId IdType="pmc">PMC8798693</ArticleId><ArticleId IdType="pubmed">35076368</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D., Moschopoulos C.D., Margalit I., Gkrania-Klotsas E., Landi F., Stahl J.P., Yahav D. ESCMID rapid guidelines for assessment and management of long COVID. Clin. Microbiol. Infect. 2022;28:955&#x2013;972. doi: 10.1016/j.cmi.2022.02.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.02.018</ArticleId><ArticleId IdType="pmc">PMC8849856</ArticleId><ArticleId IdType="pubmed">35182760</ArticleId></ArticleIdList></Reference><Reference><Citation>Bwire G.M. Coronavirus: Why men are more vulnerable to COVID-19 than women? SN Compr. Clin. Med. 2020;2:874&#x2013;876. doi: 10.1007/s42399-020-00341-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-020-00341-w</ArticleId><ArticleId IdType="pmc">PMC7271824</ArticleId><ArticleId IdType="pubmed">32838138</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortona E., Buonsenso D., Carfi A., Malorni W., The Long COVID Kids Study Group. Munblit D., De Rose C., Sinatti D., Ricchiuto A., Valentini P. Long COVID: An estrogen-associated autoimmune disease? Cell Death Discov. 2021;7:77. doi: 10.1038/s41420-021-00464-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-021-00464-6</ArticleId><ArticleId IdType="pmc">PMC8042352</ArticleId><ArticleId IdType="pubmed">33850105</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Mart&#xed;n-Guerrero J.D., Pellicer-Valero &#xd3;.J., Navarro-Pardo E., G&#xf3;mez-Mayordomo V., Cuadrado M.L., Arias-Naval&#xf3;n J.A., Cigar&#xe1;n-M&#xe9;ndez M., Hern&#xe1;ndez-Barrera V., Arendt-Nielsen L. Female sex is a risk factor associated with long-term post-COVID related-symptoms but not with COVID-19 symptoms: The LONG-COVID-EXP-CM multicenter study. J. Clin. Med. 2022;11:413. doi: 10.3390/jcm11020413.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11020413</ArticleId><ArticleId IdType="pmc">PMC8778106</ArticleId><ArticleId IdType="pubmed">35054108</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q., Xu M., Li J., Liu Y., Zhang J., Xu Y., Dong W. Clinical sequelae of COVID-19 survivors in Wuhan, China: A single-centre longitudinal study. Clin. Microbiol. Infect. 2021;27:89&#x2013;95. doi: 10.1016/j.cmi.2020.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.023</ArticleId><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F., Tomasoni D., Falcinella C., Barbanotti D., Castoldi R., Mul&#xe8; G., Augello M., Mondatore D., Allegrini M., Cona A., et al. Female gender is associated with long COVID syndrome: A prospective cohort study. Clin. Microbiol. Infect. 2022;28:611.e9&#x2013;611.e16. doi: 10.1016/j.cmi.2021.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Abumweis S., Alrefai W., Alzoughool F. Association of obesity with COVID-19 diseases severity and mortality: A meta-analysis of studies. Obes. Med. 2022;33:100431. doi: 10.1016/j.obmed.2022.100431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.obmed.2022.100431</ArticleId><ArticleId IdType="pmc">PMC9181395</ArticleId><ArticleId IdType="pubmed">35702736</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z., Peng Y., Wu X., Pang B., Yang F., Zheng W., Liu C., Zhang J. Comorbidities and complications of COVID-19 associated with disease severity, progression, and mortality in China with centralized isolation and hospitalization: A systematic review and meta-analysis. Front. Public Health. 2022;10:923485. doi: 10.3389/fpubh.2022.923485.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.923485</ArticleId><ArticleId IdType="pmc">PMC9424916</ArticleId><ArticleId IdType="pubmed">36052001</ArticleId></ArticleIdList></Reference><Reference><Citation>Mumtaz A., Sheikh A.A.E., Khan A.M., Khalid S.N., Khan J., Nasrullah A., Sagheer S., Sheikh A.B. COVID-19 vaccine and long COVID: A scoping review. Life. 2022;12:1066. doi: 10.3390/life12071066.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12071066</ArticleId><ArticleId IdType="pmc">PMC9324565</ArticleId><ArticleId IdType="pubmed">35888154</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaber T.A.Z.K., Ashish A., Unsworth A., Martindale J. Are mRNA COVID 19 vaccines safe in long COVID patients? A health care workers perspective. Br. J. Med. Pract. 2021;14:9.</Citation></Reference><Reference><Citation>Scherlinger M., Pijnenburg L., Chatelus E., Arnaud L., Gottenberg J.E., Sibilia J., Felten R. Effect of SARS-CoV-2 vaccination on symptoms from post-acute sequelae of COVID-19: Results from the nationwide VAXILONG study. Vaccines. 2021;10:46. doi: 10.3390/vaccines10010046.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10010046</ArticleId><ArticleId IdType="pmc">PMC8781023</ArticleId><ArticleId IdType="pubmed">35062706</ArticleId></ArticleIdList></Reference><Reference><Citation>Korea Disease Control and Prevention Agency (KDCA)  Korea Community Health at a Glance 2022: Korea Community Health Survey (KCHS)  [(accessed on 3 July 2023)].  Available online:  https://chs.kdca.go.kr/chs/stats/statsMain.do.</Citation></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>